Saudi Arabia Amgad Talaat, Regional Cluster Head of EVA Pharma Saudi Arabia, delves into the company’s strategic expansion in the region, emphasizing investments in local manufacturing, innovation, and team development to align with Saudi Vision 2030. With a focus on addressing unmet medical needs and fostering partnerships, EVA Pharma is positioning itself…
Puerto Rico Tom Vincent, Vice President of Prime Air Cargo, shares insights into the company’s journey as a global logistics leader headquartered in Puerto Rico, the challenges and opportunities in serving the life sciences sector, and the strategic innovations driving its success. Vincent discusses how Prime Air Cargo has adapted to evolving…
Europe The European Brain Council (EBC) is a key player in advancing brain health research and policy across Europe, bringing together diverse voices to address the pressing issues of neurological and mental health. As Frédéric Destrebecq, the EBC’s Executive Director, explains, “We must restore the trust between science and society for…
Global While many diagnostics companies have suffered from the decline in COVID-19 testing since the pandemic, the sector, expected to grow from USD 210.58 billion to reach USD 284.38 billion by 2033, continues to thrive as it brings forward new levels of innovation and precision for a range of diseases. We…
Merck Over the course of its 350-year history, Merck KGaA has expanded from its base in Darmstadt, Germany to establish a strong presence in various markets across the globe. Last year, PharmaBoardroom spoke with Merck affiliate leaders in multiple geographies, uncovering their concerns and priorities as the firm pushed to recover…
Brazil A roundup of the biggest stories from Brazil’s pharma industry, including Teuto’s cannabis manufacturing deal with MediPharm; Eurofarma’s AI-based epilepsy joint venture with SK Biopharmaceuticals; EMS’s increased stake in Hypera after a failed merger attempt, and Quantoom, Univercells and Fiocruz’s RNA-based vaccine production collaboration. MediPharm Labs Enters Landmark Commercial…
Puerto Rico Antonio Medina, CEO of Convergent Strategies, shares insights into Puerto Rico’s evolving economic landscape and the critical role his consultancy plays in driving growth and innovation across industries. He reflects on his experience guiding the island out of bankruptcy as a member of the Financial Oversight Board and discusses key…
Saudi Arabia Marwan Omar, General Manager of Ferring in the GCC, lays out the company’s growth strategy and its deep commitment to the region. With a focus on local talent development, strategic partnerships, and expanding its product portfolio, Ferring continues to strengthen its presence in reproductive medicine, gastroenterology, and uro-oncology. Investing…
Saudi Arabia Mohamed Al Holibi, Regional Business Lead for Health Information Systems at Solventum, shares insights into the evolving role of healthcare data and digital transformation in Saudi Arabia. In this interview, he discusses Solventum’s commitment to supporting Vision 2030 through advanced AI-driven technologies, the implementation of Diagnosis-Related Groups (DRG) systems, and…
Global Regular PharmaBoardroom contributor David H. Crean outlines the resilient and cautious optimism observed at JPM 2025, the annual healthcare financing conference held near San Francisco’s Union Square. While uncertainties and headwinds still persist, particularly around regulatory changes, affordability issues, and capital financing in the public and private markets, the healthcare…
Mexico This interview explores Esmeralda Ortiz’s transformative leadership at Grupo Loeffler Russek (GLR), where she has worked to professionalize operations, strengthen the product portfolio, and position the company for sustainable growth. By balancing structure with inclusivity, Ortiz implements best practices drawn from global experience while respecting GLR’s legacy as a family-owned…
Global In 2024, global biopharma faced a challenging landscape shaped by geopolitical tensions and cost containment measures in key markets. Despite these pressures, most major players perhaps surprisingly opted to retain their CEOs, focusing instead on reshaping management at other levels. Companies like Bayer underwent sweeping transformations, while others, such as…
See our Cookie Privacy Policy Here
